-

Citi Appointed as Depositary Bank for Abivax SA’s ADR Program

LONDON--(BUSINESS WIRE)--Citi, acting through Citibank N.A., has been appointed by Abivax SA (“Abivax”), to act as depositary bank for its initial public offering (the “IPO”) of Abivax’s American Depositary Shares (“ADSs” or “ADRs”) representing its ordinary shares.

Abivax’s ADSs trade on the Nasdaq Global Market under the ticker symbol “ABVX”. The company’s underlying ordinary shares are listed on Euronext Paris under the symbol “ABVX”. Each ADS represents one ordinary share of the company.

Commenting on the appointment, Dirk Jones, Global Head of Issuer Services, at Citi said: “We look forward to supporting Abivax’s ADR program and expanding the company’s investor outreach through the expertise of our Investor Relations Advisory team and the breadth of our global equity distribution network.”

Citi is a leading provider of depositary receipt services. With depositary receipt programs in 67 markets, spanning equity and fixed-income products, Citi leverages its global network to provide cross-border capital market access to issuers, intermediaries, and investors.

For more information on Citi’s Depositary Receipt Services, visit www.citi.com/dr .

About Abivax

Abivax is a clinical-stage biotechnology company focused on developing therapeutics that harness the body’s natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases.

For more information on Abivax, visit https://www.abivax.com/.

About Citi

Citi is a preeminent banking partner for institutions with cross-border needs, a global leader in wealth management and a valued personal bank in its home market of the United States. Citi does business in nearly 160 countries and jurisdictions, providing corporations, governments, investors, institutions, and individuals with a broad range of financial products and services.

Additional information may be found at www.citigroup.com | Twitter: @Citi | LinkedIn: www.linkedin.com/company/citi | YouTube: www.youtube.com/citi | Facebook: www.facebook.com/citi

Contacts

Citi Media Contacts:
Richard Bicknell
+44 (0) 20 7500 5003
richard.bicknell@citi.com

Citi

NYSE:C

Release Versions

Contacts

Citi Media Contacts:
Richard Bicknell
+44 (0) 20 7500 5003
richard.bicknell@citi.com

More News From Citi

Citi Advances Real-Time Asset Servicing Globally with Single Event Processing

LONDON--(BUSINESS WIRE)--Citi Investor Services, which delivers the bank’s leading and comprehensive post-trade platform, has marked a significant step in its advancement of real-time asset servicing with the launch of its Single Event Processing (SEP) technology. The bank expects the majority of its custody flows to be processed using SEP by 2026. SEP unifies Citi’s global and direct custody infrastructure so that every asset servicing transaction will be processed in real-time through a singl...

Citi Whitepaper: Global Post-Trade Industry Poised for Further Transformation Driven by Digital Assets, Accelerated Settlements and the Adoption of AI

LONDON--(BUSINESS WIRE)--Citi’s latest “Securities Services Evolution” whitepaper details how the global post-trade industry is poised for further transformation in speed, resilience and the cost of trade processing. Following years of groundwork, market participants are now focused on execution, and the delivery of initiatives to drive heightened efficiencies and innovation. Citi’s fifth and latest edition of the annual whitepaper polled 537 industry leaders – the largest participation so far...

Citi Appointed as Depositary Bank for Nightingale Health OYJ’s ADR Program

LONDON--(BUSINESS WIRE)--Citi Issuer Services, acting through Citibank N.A., has been appointed by Nightingale Health OYJ (“Nightingale Health”) to act as depositary bank for its sponsored Level 1 American Depositary Receipt (“ADR”) program. Nightingale Health’s ADRs are traded on the OTCQX platform under the symbol “NHLTY”. Each ADR represents one ordinary share of the company. Nightingale Health’s underlying ordinary shares are listed and traded on the Nasdaq Helsinki Stock Exchange under the...
Back to Newsroom